Last updated on June 2018

A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia


Brief description of study

The main purpose of this study is to evaluate the efficacy of the study drug known as lanabecestat in participants with mild Alzheimer's disease (AD) dementia.

Clinical Study Identifier: NCT02783573

Contact Investigators or Research Sites near you

Start Over

Stephen Flitman

Xenoscience
Phoenix, AZ United States

Marwan Sabbagh

St Josephs Hospital and Medical Center
Phoenix, AZ United States

Constantine Moschonas

Four Peaks Neurology
Scottsdale, AZ United States

Dennis Swearingen

Arizona Neurology
Scottsdale, AZ United States

Michael Badruddoja

Center for Neurosciences
Tucson, AZ United States

Kenneth Chan

NEA Baptist Clinical
Jonesboro, AR United States

BENJAMIN FRISHBERG

The Research Center of Southern California
Carlsbad, CA United States

Roginelli Yu

WCCT Global
Costa Mesa, CA United States

Perminder Bhatia

Neuro-Pain Medical Center
Fresno, CA United States

Johnson Moon

Neurology Center of North Orange County
Fullerton, CA United States

James Sutton

Pacific Neuroscience Medical Group
Oxnard, CA United States

D BRANDON

California Research Foundation
San Diego, CA United States

Stephen Thein

Pacific Research Network Inc
San Diego, CA United States

MICHAEL PLOPPER

Sharp Mesa Vista Hospital
San Diego, CA United States

Adam Boxer

Univ of California San Francisco
San Francisco, CA United States

John Duffy

Syrentis Clinical Research
Santa Ana, CA United States

Surisham Dhillon

Care Access Research
Santa Clarita, CA United States

THOMASSHIOVITZ THOMAS SHIOVITZ

California Neuroscience Research
Sherman Oaks, CA United States

Mehdi Meratee

Care Access Research
Valencia, CA United States

John Olichney

University of California, Davis - Health Systems
Walnut Creek, CA United States

Samuel Markind

Associated Neurologists, PC - Danbury
Danbury, CT United States

David Russell

Institute for Neurodegenerative Disorders
New Haven, CT United States

CHRIS VAN DYCK

Yale University School of Medicine
New Haven, CT United States

Bart Sloan

Research Center fro Clinical Studies, Inc
Norwalk, CT United States

Mark Goldstein

JEM Research Institute
Atlantis, FL United States

Diana Pollock

Morton Plant Hospital
Clearwater, FL United States

Mark Brody

Brain Matters Research
Delray Beach, FL United States

Robert Cohen

Cohen Medical Associates P.A.
Delray Beach, FL United States

Frederick Schaerf

Neuropsychiatric Research Center of Southwest Florida
Fort Myers, FL United States

Jose Cardona

Indago Research & Health Center, Inc.
Hialeah, FL United States

Harvey Schwartz

Infinity Clinical Reserach . LLC
Hollywood, FL United States

Erin Doty

Jacksonville Center for Clinical Research
Jacksonville, FL United States

There may be multiple sites ...

Mayo Clinic of Jacksonville
Jacksonville, FL United States

Gregory Kirk

Gregory A. Kirk MD LLC
Merritt Island, FL United States

B BAUMEL

University of Miami
Miami, FL United States

Michael Pfeffer

Allied Biomedical Research Institute, Inc.
Miami, FL United States

Craig Curtis

Compass Research
Orlando, FL United States

Jose De La Gandara

Quantum Laboratories
Pompano Beach, FL United States

Ramon Gil

Charlotte Neurological Services
Port Charlotte, FL United States

Mauricio Concha

Intercoastal Medical Group
Sarasota, FL United States

Susan Steen

Axiom Research
Tampa, FL United States

Amanda Smith

Johnnie B Byrd, Sr. Alzheimer's Center and Research Institut
Tampa, FL United States

Allan Levey

Emory University
Atlanta, GA United States

There may be multiple sites ...

Atlanta Center of Medical Research
Atlanta, GA United States

John Morgan

Georgia Regents University
Augusta, GA United States

Jonathan Liss

Medical Research Health and Education Foundation, Inc
Columbus, GA United States

Kore Liow

Hawaii Medical Center
Honolulu, HI United States

Mark Turner

Advanced Clinical Research LLC
Meridian, ID United States

Mark Benson

American Health Network
Avon, IN United States

KRISTI GEORGE

Josephson Wallack Munshower Neurology
Indianapolis, IN United States

Jonathan Condit

American Health Network
Muncie, IN United States

Jeffrey Burns

University of Kansas Hospital
Fairway, KS United States

Scott Teeter

Cotton O'Neil Clinic
Topeka, KS United States

Paul Murphy

Via Christi Research, Inc.
Wichita, KS United States

Greg Cooper

Baptist Health Medical Group
Lexington, KY United States

There may be multiple sites ...

Associates in Neurology, PSC
Lexington, KY United States

Clifford Singer

Eastern Maine Medical Center
Bangor, ME United States

Eric Dinnerstein

Maine Neurology
Scarborough, ME United States

Robert Stern

Boston University Medical Center
Boston, MA United States

Donald Marks

Donald S Marks
Plymouth, MA United States

Anil Nair

Alzheimers Disease Center
Winchester, MA United States

Andrea Bozoki

Michigan State University
East Lansing, MI United States

Michael Rosenbloom

HealthPartners Center for Memory and Aging
Bloomington, MN United States

Ronald Schwartz

Hattiesburg Clinic
Hattiesburg, MS United States

Timothy Jennings

Clinical ResearchProfessionals
Saint Louis, MO United States

Bharat Mocherla

Las Vegas Medical Research
Las Vegas, NV United States

Sanjiv Sharma

Advanced Memory Research Institute of New Jersey
Toms River, NJ United States

Noah Gilson

Neurology Specialists of Monmouth County
West Long Branch, NJ United States

Melanie Shulman

New York University Medical Center
New York, NY United States

Oleg Tcheremissine

Behavioral Health Center Research
Charlotte, NC United States

Bradley Robottom

Raleigh Neurology Associates
Raleigh, NC United States

Giles Crowell

PMG Research of Winston-Salem, LLC
Winston-Salem, NC United States

Kaycee Sink

Wake Forest Baptist Univ CAR
Winston-Salem, NC United States

Mary Manning

Rapid Medical Research Inc
Cleveland, OH United States

Douglas Scharre

Ohio State University Medical Center
Columbus, OH United States

Deborah Gould

Insight Clinical Trials
Shaker Heights, OH United States

Carl Griffin

Lynn Health Science Institute
Oklahoma City, OK United States

Willis Holloway

Cutting Edge Research Group
Oklahoma City, OK United States

Weijia Wang

The Corvallis Clinic P.C.
Corvallis, OR United States

Scott Losk

Summit Research Network Inc
Portland, OR United States

Marvin Kalafer

Clinical Trial Center, LLC, Psychiatry
Jenkintown, PA United States

Robert Pearlstein

Pearl Clinical Research Inc.
Norristown, PA United States

John Stoukides

Rhode Island Mood & Memory Research Institute
East Providence, RI United States

Brian Ott

Rhode Island Hospital
Providence, RI United States

Stephen Salloway

Butler Hospital
Providence, RI United States

There may be multiple sites ...

Medical University of South Carolina
Charleston, SC United States

William Ellison

Radiant Research
Greer, SC United States

Paul Mazzeo

Coastal Neurology PA
Port Royal, SC United States

David Morin

Holston Medical Group Clinical Research
Kingsport, TN United States

Mary Quiceno

University of Texas Southwestern Medical Center at Dallas
Dallas, TX United States

Janice Knebl

Univ of North Texas Health Science Center
Fort Worth, TX United States

Tyler Dixon

Ericksen Research and Development
Clinton, UT United States

JOSEPH TORNABENE

Wenatchee Valley Hospital & Clinics
Wenatchee, WA United States

Anne Koplin

Dean Foundation for Health Research and Education
Middleton, WI United States

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Brussels, Belgium

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Calgary, Canada

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Gatineau, Canada

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Halifax, Canada

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Montreal, Canada

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Ottawa, Canada

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Peterborough, Canada

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Sherbrooke, Canada

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Toronto, Canada

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician.
Verdun, Canada

Eli Lilly and Company

"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician."
West Vancouver, Canada

Eli Lilly and Company

"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician."
Beijing, China

Eli Lilly and Company

"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician."
Hebei, China

Eli Lilly and Company

"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician."
Nanjing, China

Eli Lilly and Company

"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician."
Shandong, China

Eli Lilly and Company

"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician."
Shanghai, China

Eli Lilly and Company

"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician."
Sichuan, China

Eli Lilly and Company

"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician."
Yangzhou, China

Eli Lilly and Company

"For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician."
Zhejiang, China

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Brno, Czechia

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Chocen, Czechia

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Guangdong, China

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Nanjing, China

Eli Lilly and Company

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Wenzhou, China